[Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
Kamiya
O
O
Dept. of Internal Medicine, Anjou Kosei Hospital.
Hoshino
A
A
Ohara
K
K
Nagata
K
K
Ono
Y
Y
Saito
M
M
Itou
T
T
Yamamoto
K
K
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D004586:Electrophoresis; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy*; D009194:Myeloma Proteins / Q000097:blood*; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D017663:Peplomycin; D011239:Prednisolone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage
D009194:Myeloma Proteins; D009607:Nitrosourea Compounds; D001761:Bleomycin; D011344:Procarbazine; D017663:Peplomycin; D004317:Doxorubicin; D011239:Prednisolone; D002945:Cisplatin; D008558:Melphalan; D005472:Fluorouracil